Caribou Biosciences Income Statement (2020-2025) | CRBU

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.70M8.48M1.20M0.98M1.59M1.48M3.98M2.56M2.66M4.19M3.30M3.69M3.50M3.75M23.66M3.56M2.43M3.46M2.02M2.08M2.35M2.67M2.20M
Operating items
Research & Development 8.64M7.58M6.18M12.02M10.16M12.33M15.83M15.11M13.92M22.58M19.99M25.74M25.71M26.50M28.58M31.28M33.79M35.48M30.42M30.46M35.53M27.69M22.40M
Selling, General & Administrative 3.49M3.15M3.25M4.17M4.60M5.11M6.76M7.85M9.59M10.04M9.85M8.53M8.91M10.12M9.71M9.72M14.64M11.48M9.84M10.49M9.73M10.40M9.20M
Other Operating Expenses 12.15M
Operating Expenses 12.13M10.73M9.43M16.20M14.76M17.44M22.59M22.96M23.52M32.62M29.84M34.27M34.62M36.62M38.30M41.00M48.43M46.97M40.26M40.95M45.27M50.24M31.60M
Operating Income -10.43M-2.25M-8.23M-15.21M-13.18M-15.96M-18.62M-20.41M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M
EBIT -10.43M-2.25M-8.23M-15.21M-13.18M-15.96M-18.62M-20.41M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M
Non-operating items
Non Operating Investment Income -0.95M-0.49M
Interest & Investment Income 0.01M0.00M0.08M0.05M0.02M0.08M
Other Non Operating Income 0.33M0.09M0.08M0.02M0.07M0.04M0.26M0.70M1.47M2.33M2.83M3.05M4.77M4.82M4.46M4.01M3.72M3.16M2.59M2.19M1.85M
Non Operating Income -0.57M0.33M0.08M0.15M0.02M1.65M-2.36M2.25M1.76M1.73M-0.11M3.66M3.07M3.35M4.63M3.13M4.77M5.80M3.55M3.38M2.92M-6.52M1.85M
Net income details
EBT -11.00M-1.92M-8.15M-15.06M-13.16M-14.31M-20.97M-18.16M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M
Tax Provisions -1.20M-0.05M-0.21M-0.35M0.32M
Profit After Tax -9.80M-1.87M-7.93M-14.70M-13.16M-14.31M-20.97M-18.48M-19.09M-26.70M-26.65M-26.99M-28.04M-29.52M-10.00M-34.51M-41.23M-37.70M-34.68M-35.49M-40.00M-54.10M-27.55M
Equity Income -0.09M-0.02M0.03M-0.06M-0.01M0.02M-0.00M-0.01M-0.10M-0.01M
Income from Continuing Operations -9.80M-1.87M-7.93M-14.70M-13.16M-14.31M-20.97M-18.48M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M
Consolidated Net Income -9.80M-1.87M-7.93M-14.70M-13.16M-14.31M-20.97M-18.48M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M
Income towards Parent Company -9.80M-1.87M-7.93M-14.70M-13.16M-14.31M-20.97M-18.48M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M
Net Income towards Common Stockholders -9.80M-1.87M-7.93M-14.70M-13.16M-14.31M-20.97M-18.48M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M
Additional items
EPS (Basic) -1.16-0.22-0.93-1.68-1.39-1.39-0.46-0.58-0.32-0.44-0.44-0.45-0.46-0.48-0.12-0.40-0.46-0.42-0.38-0.43-0.43-0.58-0.30
EPS (Weighted Average and Diluted) -1.39-0.460.09-0.32-0.44-0.44-0.45-0.46-0.48-0.12-0.40-0.46-0.42-0.38-0.43-0.43-0.58-0.30
Shares Outstanding (Weighted Average) 8.43M8.44M8.54M8.78M9.50M10.26M45.89M31.66M60.55M60.76M60.89M60.80M61.19M61.42M83.78M73.81M89.30M90.34M90.46M90.32M92.68M93.03M93.29M
Shares Outstanding (Diluted Average) 10.26M45.89M31.66M60.55M60.76M60.89M60.80M61.19M61.42M83.78M73.81M89.30M90.34M90.46M90.32M92.68M93.03M93.29M
EBITDA -10.43M-2.25M-8.23M-15.21M-13.16M-14.31M-20.97M-18.61M-20.04M-27.19M-27.10M-26.47M-27.26M-29.93M-9.85M-33.49M-41.59M-37.69M-33.58M-36.02M-40.08M-54.23M-27.50M
Interest Expenses 0.01M0.01M0.01M0.00M
Tax Rate 10.93%2.60%2.61%2.35%-1.77%